Acute decompensated heart failure

Results from the phase 2b ixCELL-DCM clinical study of Ixmyelocel-T in patients with advanced heart failure due to ischemic dilated...


A study sought to hypothesize that elevated B-type natriuretic peptide ( BNP ) could act as an endogenous neprilysin inhibitor. A...


Patients with acute heart failure ( AHF ) commonly have multiple co-morbidities, and some of these patients die in the...


The drug Levosimendan ( Simdax ) did not improve survival for patients with decompensated heart failure when compared with a...


A blood test for patients with coronary heart disease could help predict their risk for subsequent cardiovascular events or death. Risk...


Although acutely decompensated heart failure is a very common cause of hospitalization, most treatments commonly used have not been validated...


In 2001, Nesiritide ( Natrecor ) has been approved by the FDA for the intravenous treatment of patients with acutely...


Scios and FDA notified HealthCare Professionals of revisions to the Adverse Reactions / Effect on Mortality section of the prescribing...


An Expert Panel, chaired by Eugene Braunwald, met on June 8th to review and assess important data associated with the...


Researchers from the University of Massachusetts Medical School looked at the incidence of heart failure in residents of the Worcester,...


Investigators at UCLA ( University of California, Los Angeles ) found large gaps and marked variation in U.S. hospitals' heart...


Eric J. Topol, chair of the Department of Cardiovascular Medicine at the Cleveland Clinic, asks, How can a drug that...


A meta-analysis of previous studies indicates that use of a pulmonary artery catheter ( PAC ) in critically ill patients...